Platelet-associated CD154 in immune thrombocytopenic purpura
- PMID: 15191945
- DOI: 10.1182/blood-2003-07-2367
Platelet-associated CD154 in immune thrombocytopenic purpura
Abstract
CD40-ligand (CD154) is expressed on activated CD4+ T lymphocytes and is essential for the T cell-dependent activation of B lymphocytes. CD154 is also expressed at the activated platelet surface. In this study, we show that platelet-associated CD154 is increased in immune thrombocytopenic purpura (ITP), a disease characterized by an autoimmune response against proteins of the platelet membrane. CD154 and its messenger RNA were also present in increased amounts in the megakaryocytes of patients with ITP. We found that platelet-associated CD154 is competent to induce the CD40-dependent proliferation of B lymphocytes, and we observed an in vitro CD154-dependent production of antibodies to the GPIIb/IIIa complex (integrin alphaIIbbeta3) when platelets and peripheral blood B lymphocytes from ITP patients with circulating anti-GPIIb/IIIa antibody were cultured together. Therefore, platelet-associated CD154 expression is increased in ITP and is able to drive the activation of autoreactive B lymphocytes in this disease.
Similar articles
-
The role of platelet CD154 in the modulation in adaptive immunity.Immunol Res. 2007;39(1-3):185-93. doi: 10.1007/s12026-007-0074-3. Immunol Res. 2007. PMID: 17917065 Review.
-
Autoimmune thrombocytopenia: flow cytometric determination of platelet-associated CD154/CD40L and CD40 on peripheral blood T and B lymphocytes.Hematology. 2007 Aug;12(4):301-7. doi: 10.1080/10245330701383957. Hematology. 2007. PMID: 17654056
-
Effect of a single injection of humanized anti-CD154 monoclonal antibody on the platelet-specific autoimmune response in patients with immune thrombocytopenic purpura.Blood. 2004 Feb 15;103(4):1229-36. doi: 10.1182/blood-2003-06-2167. Epub 2003 Oct 9. Blood. 2004. PMID: 14551140 Clinical Trial.
-
Suppression of autoreactive T-cell response to glycoprotein IIb/IIIa by blockade of CD40/CD154 interaction: implications for treatment of immune thrombocytopenic purpura.Blood. 2003 Jan 15;101(2):621-3. doi: 10.1182/blood-2002-07-2157. Epub 2002 Aug 22. Blood. 2003. PMID: 12393517
-
Platelet influence on T- and B-cell responses.Arch Immunol Ther Exp (Warsz). 2009 Jul-Aug;57(4):235-41. doi: 10.1007/s00005-009-0032-y. Epub 2009 Jul 4. Arch Immunol Ther Exp (Warsz). 2009. PMID: 19578816 Review.
Cited by
-
The role of platelet CD154 in the modulation in adaptive immunity.Immunol Res. 2007;39(1-3):185-93. doi: 10.1007/s12026-007-0074-3. Immunol Res. 2007. PMID: 17917065 Review.
-
HIV-1 Tat-induced platelet activation and release of CD154 contribute to HIV-1-associated autoimmune thrombocytopenia.J Thromb Haemost. 2011 Mar;9(3):562-73. doi: 10.1111/j.1538-7836.2010.04168.x. J Thromb Haemost. 2011. PMID: 21143381 Free PMC article.
-
Decreased plasma cytokines are associated with low platelet counts in aplastic anemia and immune thrombocytopenic purpura.J Thromb Haemost. 2012 Aug;10(8):1616-23. doi: 10.1111/j.1538-7836.2012.04757.x. J Thromb Haemost. 2012. PMID: 22537155 Free PMC article.
-
Severe Refractory Immune Thrombocytopenia Successfully Treated with High-Dose Pulse Cyclophosphamide and Eltrombopag.Case Rep Hematol. 2015;2015:583451. doi: 10.1155/2015/583451. Epub 2015 Jun 9. Case Rep Hematol. 2015. PMID: 26180646 Free PMC article.
-
The platelet as an immune cell-CD40 ligand and transfusion immunomodulation.Immunol Res. 2009 Dec;45(2-3):251-60. doi: 10.1007/s12026-009-8106-9. Epub 2009 Jan 29. Immunol Res. 2009. PMID: 19184537 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials